Industry reports
Editor highlights

Valeant Pharmaceuticals International Market and Forecasts, April 2014

You might be interested in: stem cell, atopic dermatitis, water


 

» View Public Reports

1-17 of 25 reports for Valeant Pharmaceuticals I...

Investment Banking Sector in Canada

  • Industry report
  • January 2014
  • 4 pages

... Some shareholder friendly strategies. valeant pharmaceuticals international inc. Is the largest in canada and has made some key acquisitions to help fuel growth. This is held for clients in our ...

U.S. Food Industry : Production and Trade Statistics

  • Industry report
  • February 2012
  • 4 pages

... Around the world valeant acquires brazilian food supplement company for $86m valeant pharmaceuticals international has acquired probiotica laboratorios, a brazilian sports nutrition and food supplement ...

U.S. Nursing Home Industry Brief

  • Industry report
  • April 2013
  • 16 pages

... Medical products, inc. valeant pharmaceuticals international $323.5 2.5X 13.9X pharma pending palomar medical technologies inc. Cynosure, inc. $208.9 2.4X 32.7X hc equip. Pending althea technologies, inc ...

Investment Banking Sector in Canada

  • Industry report
  • April 2012
  • 12 pages
  • by Corporation

... In the long run, will ensure china s prosperity. Deal making in growth markets did not come to a complete standstill. Two notable canadian-led buys included: valeant pharmaceuticals international announced ...

Chemical and Material Sector in The United States, Canada and China

  • Industry report
  • March 2012
  • 8 pages

... Profit slipped to a first-quarter loss of $33.3 Million, due to a tax reassessment. valeant pharmaceuticals international (vrx) said it is expanding its presence in eastern europe by acquiring austrian ...

Drug Delivery Technology Industry Brief

  • Industry report
  • September 2012
  • 24 pages

... Are registered trademarks of basf se. Osdrc is a registered trademark of sanwa kagaku kenkyusho co, ltd. Zelapar is a registered trademarks of valeant pharmaceuticals international, inc. Eldepryl ...

The Indian Tourism and Leisure Business : Production and Trade Statistics

  • Industry report
  • April 2012
  • 16 pages
  • by Market Research Publisher

... Canada-based valeant pharmaceuticals international inc agreed to buy russian pharma company natur produkt international, jsc for about us$ 180 million to tap into the otc market in the country. Budget impact analysis ...

Diagnostics Industry Trends

  • Industry report
  • September 2013
  • 66 pages

... The key vendors dominating this space include allergan inc., Galderma s.A., Merz pharma gmbh & co. Kgaa, and valeant pharmaceuticals international inc. - Pub ...

Medical Technology Report 2013

  • Industry report
  • June 2012
  • 64 pages
  • by Corporation

... Us$m) thermo fisher scientific us massachusetts life technologies us california $15,800 valeant pharmaceuticals international canada bausch & lomb us new york $8,700 baxter international us ...

Energy & Environment : Sector Overview and Key Players

  • Industry report
  • February 2013
  • 51 pages

... European countries, north and latin americas, asia, africa and middle east. In december 2012, sanofi announced that it completed the divestiture of its dermatology business, dermik, to valeant ...

» Purchase Premium Reports (From $ 125 - $ 6 650)

58 reports for Valeant Pharmaceuticals I...
Global Glaucoma Therapeutics Market  2014-2018

Global Glaucoma Therapeutics Market 2014-2018

  • $ 2 500
  • Industry report
  • April 2014
  • by Infiniti Research Limited

About Glaucoma Therapeutics Glaucoma is a disease of the eye in which fluid pressure within the eye increases. If left untreated the patient may lose vision and even become blind. The exact etiology of ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.